Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Brain Neoplasms × Bortezomib × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 26 Immunoglobulin Light-chain Amyloidosis 5 Paraproteinemias 3 Neoplasms, Plasma Cell 2 Neoplasms 2 Lymphoproliferative Disorders 2 beta-Thalassemia 1 Waldenstrom Macroglobulinemia 1 Thalassemia 1 Renal Insufficiency 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1 Lymphadenopathy 1 Leukemia, Myeloid, Acute 1 Immunoproliferative Disorders 1 Hematologic Neoplasms 1 HIV Infections 1 Anemia, Sickle Cell 1 Amyloidosis 1

Interventions

Radiosurgery 11 Magnetic Resonance Spectroscopy 8 Temozolomide 7 Bevacizumab 6 Specimen Handling 5 trastuzumab deruxtecan 4 pembrolizumab 4 Radiotherapy 4 Nivolumab 4 Cyclophosphamide 4 Biopsy 4 abemaciclib 3 Ipilimumab 3 entrectinib 2 cabozantinib 2 Trastuzumab 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Sirolimus 2 Receptors, Interleukin-8B 2 Mental Status and Dementia Tests 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Dexamethasone 2 Adrenal Cortex Hormones 2 trastuzumab biosimilar HLX02 1 temsirolimus 1 ribociclib 1 repotrectinib 1 regorafenib 1 pertuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡